PUF60 and gastric cancer: Especially, the expression of PUF60 in GC patients treated with 5-FU based chemotherapy was negatively associated with overall survival (OS, HR = 1.87, p=0.0013) and first progression (FP, HR= 1.76, p=0.0027).